MedTrace Logo

Identify Bacteria Associated With Metabolic Diseases That Reside Both in Intestinal Crypts and in Blood

NCT02261831 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2018-12-03

No results posted yet for this study

Summary

The investigators will compare 16sRDNA profile in cases and controls in order to identify bacteria associated with metabolic diseases that reside both in intestinal crypts and in blood.

Conditions

Interventions

OTHER

obese patients

collection of blood sampling and biopsies

OTHER

diabetic patients

collection of blood sampling and biopsies

OTHER

patients free of obesity and diabetes

collection of blood sampling and biopsies

OTHER

patients free type 2 diabetes

collection of blood sampling and biopsies

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Jacques AMAR, MD PhD · University Hospital, Toulouse

  • Jacques Moreau, MD · University Hospital, Toulouse

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02261831 on ClinicalTrials.gov